# Ataraxa LP — Form D

Ataraxa LP of NEW YORK, NY, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2025-01-30. $1.0M was reported sold. Industry: Pooled Investment Fund.

## Offering

- Filed: 2025-01-30
- Form: D
- Accession: 0001562555-25-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1
- Amount sold: $1.0M
- Minimum investment: $10K
- Investors: 8
- Date of first sale: 2025-01-15
- Security types: fund interests
- SEC file number: 021-536778

## Issuer

- Name: Ataraxa LP
- CIK: 0002053057
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 817 BROADWAY, NEW YORK, NY, 10003
- Phone: 347-614-2682

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| n/a Ataraxa GP LLC | Executive Officer | New York, NY |
| n/a Avenir Management Company, LLC | Executive Officer | New York, NY |
| James Reynolds IV | Promoter | New York, NY |
| Andrew Sugrue | Promoter | NEW YORK, NY |

## More

- [CIK 2053057 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2053057&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001562555-25-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.